Qiagen INC:1110297 [18-002781] POP 3/29/2018 - 3/28/2018
Ended Awarded
- Contract number
- HHSN26400004
- Awardee
-
Qiagen, LLC UEI W2GLKC92ZH73 Part of Qiagen N.V.
- Awarding agency
-
National Insititue of Arthritis and Musculoskeletal and Skin Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $12,917
Award facts
- Contract value 100% obligated
- $12,917.32 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 334516 Analytical Laboratory Instrument Manufacturing
- PSC
- 6810 Chemicals
- Set-aside
- No set-aside
- Competition
- Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Bethesda, MD 20892, USA
Award details come from SAM.gov/FPDS.
About this award
Qiagen, LLC received a Blanket Purchase Agreement (BPA) call-order award from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), a civilian agency under the National Institutes of Health, for $12,917.32. The award was issued on March 29, 2018, under a firm fixed-price contract structure with an ultimate completion date of April 30, 2018. The contract utilized no set-aside designation, allowing Qiagen to compete directly in the open federal marketplace. The place of performance is listed as Bethesda, Maryland, where NIAMS maintains its headquarters.
This call order represents a task against a larger BPA vehicle, reflecting Qiagen's established position as a provider of molecular diagnostics products, reagents, and scientific equipment to the NIH and related federal agencies. Qiagen, LLC operates as a subsidiary of Netherlands-based parent company Qiagen N.V., a multinational biotechnology firm specializing in sample and assay technologies for research and diagnostics. The company's federal contract portfolio demonstrates consistent delivery of advanced laboratory instrumentation, diagnostic testing kits, reagents, and consumables across multiple agencies including the Centers for Disease Control and Prevention, Department of Veterans Affairs, and Department of Defense.
Quick answers
Who was awarded contract HHSN26400004?
HHSN26400004 was awarded to Qiagen, LLC by National Insititue of Arthritis and Musculoskeletal and Skin Diseases (National Institutes of Health) on March 29, 2018.
How much is contract HHSN26400004 worth?
The government has obligated $12,917 on HHSN26400004.
Is contract HHSN26400004 an order under another contract?
Yes. HHSN26400004 is a BPA call under HHSN263201500079B, a blanket purchase agreement.
Was contract HHSN26400004 competed?
The extent of competition for HHSN26400004 was competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award